Product Name:Manufacturer:Bactrim, Aurobindo, Novartis
Active Ingredient:Strength:10 MG
Product Type:Tablet
Product size:4 Tablets
Packaging Type:Strips
Manufactured By:
Delivery Time:2-3 Days
Bactrim DS CAPSULE 1 TABLET is a combination of two active ingredients: Bactrim DS and aminoglycosides. Aminoglycosides work by stopping the growth of bacteria.
Bactrim DS tablet is indicated for the treatment of severe infections of the urinary tract (including pyelonephritis and cystitis), lower respiratory tract infections, skin and soft tissue infections, acute otitis media, and anthrax exposure.
The indications and contraindications of the use of Bactrim DS tablet are listed below. The indications, indications for use, and contraindications for Bactrim DS tablet are listed in order of decreasing severity from indications.
Bactrim DS tablet is given to the following patients:
This product is not intended for use in women and is not expected to provide additional benefit for children.
The patient should be advised to avoid contact with the patient's eyes during the treatment. If the patient experiences an allergic reaction, contact the physician who administered the medicine. In patients who do not have any other medical conditions, the physician may prescribe the Bactrim DS tablet as a substitute for aminoglycosides.
Bactrim DS Tablet is administered orally. The usual dose of Bactrim DS Tablet is 1 tablet per day.
The main indication for the use of Bactrim DS Tablet is to treat severe infections of the urinary tract (including pyelonephritis and cystitis), lower respiratory tract infections, skin and soft tissue infections, acute otitis media, and anthrax exposure.
The indications and contraindications of the use of the Bactrim DS tablet are listed below.
Bactrim: a Comprehensive Overview
Bactrim (doxycycline) is a broad-spectrum antibiotic that works by inhibiting bacterial protein synthesis. It is commonly used to treat a variety of bacterial infections, such as acne, respiratory tract infections, urinary tract infections, and sexually transmitted diseases. Bactrim is available in a variety of strengths, including 1mg/kg, 2.5mg, and 5mg/mL. This broad-spectrum medication has been proven effective against a wide range of bacterial infections. Bactrim is often recommended for individuals who are at least 65 years old and have certain medical conditions. It's important to note that Bactrim is not intended for pediatric use; it is intended for adults who have difficulty swallowing pills, and should be stored in a cool, dry place.
Bactrim (doxycycline) is a versatile medication that is used to treat a variety of bacterial infections, including those affecting the skin, respiratory tract, urinary tract, and sexually transmitted diseases. Bactrim is available in several strengths, including 1mg/kg, 2.5mg/mL, and 5mg/mL. It is typically prescribed for children who are at least 5 years old and have certain medical conditions, such as liver disease and kidney disease. Bactrim is also available in oral solution, tablet, and suspension for oral administration. It's important to note that Bactrim should not be used for more than 3 consecutive days.
Salt Composition in both
Sulfamethoxazole 800mg + Trimethoprim 160mg
Salt Composition
(same for both)
You Searched
Strip of 10 tablets
We only sell the best substitute from top brands
Our Recommendation
Co Trimoxazole DS 800/160mg Tablet 10s
1,696+ Customers trust this
WHO GMP Certified
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
Yes NOCurrentruuartie.comView Moreclicking on theMore videos using the tool are video links for personal use only.
Medically reviewed by Jessica Swirble, PharmDLast updated on April 18, 2025
Drug Information| | |
is a highly effective combination therapy for treating infections such as urinary tract infections, ear infections, respiratory infections, and sexually transmitted diseases.
Stable Antimicrobial potency has been demonstrated in clinical studies. Bactrim has a well-established safety profile, including an activity against both gram-positive and gram-negative bacteria.
Trimethoprim is a more selective inhibitor of fme/Trim
than
Amerin Healthcare & Co., Ltd. In combination with Bactrim, patients can experience a range of bacterial infections, from urinary tract infections to certain sexually transmitted diseases (STDs).
Trimethoprim can be used to treat certain types of bacterial infections, such as urinary tract infections, ear infections, pneumonia, and sexually transmitted diseases (STDs). Bactrim, on the other hand, works by blocking bacterial protein synthesis, thus killing the bacteria and preventing their growth and multiplication.
Trimethoprim is effective against many types of bacteria, including gram-negative bacteria, and is often the first-line treatment option for urinary tract infections (UTIs) and respiratory infections.
The choice of bacteria, as well as the types of infection being treated, should be made based on individual patient factors, like age, overall health, and the severity of the infection.
While Trimethoprim is effective against many types of bacteria, it may not be suitable for patients who have certain conditions or have impaired kidney function.
If the patient is on dialysis, the risk of kidney damage due to infections due to chronic kidney disease should be consideration. Bactrim, on the other hand, can also be used to treat certain types of infections, such as urinary tract infections and certain types of pneumonia.
Patients should be monitored for the development of drug-resistant bacteria when taking Bactrim, as well as the emergence of further infections after prolonged use.
Trimethoprim is not indicated for use in children under 12 years in which the age of absorption, distribution, or efficacy cannot be proven.
Alternative antibiotics such as penicillin-class antibacterial drugs have shown promise in treating infections such as urinary tract infections and certain types of pneumonia. However, they may not be effective in treating other types of infections, such as infections of the blood, the genital tract, the respiratory tract, and the urinary tract.
Alternative antibiotics such as amoxicillin-class antibacterial drugs have shown promise in treating infections such as urinary tract infections and certain types of pneumonia.
Antibiotics such as amoxicillin-class antibacterial drugs may not be as effective for certain infections as the antibiotic class would like them for others. For example, amoxicillin, a type of antibiotic used to treat infections such as sinusitis, can be effective against a wide range of bacteria.
The efficacy of antibiotics in treating infections is not always proven. For example, penicillin-class antibacterial drugs such as amoxicillin, a type of antibiotic used to treat infections such as sinusitis, may not be effective as an antibiotic in treating infections such as UTIs and certain types of pneumonia.
Antibiotics such as penicillin-class antibacterial drugs may not be as effective for certain infections as the antibiotic class would like them for others.
The aim of this study was to determine the impact ofBactrimon the pharmacokinetics of sulfamethoxazole and trimethoprim. A total of 240 patients were enrolled in a double-blind, randomised, placebo-controlled, crossover study, in which sulfamethoxazole 500 mg twice daily for 12 weeks was compared with trimethoprim 400 mg twice daily for 12 weeks. The results showed thathad a significantly higher mean serum sulfamethoxazole concentration compared with sulfamethoxazole alone. The mean urinary sulfamethoxazole concentration in patients with renal impairment was 3.4% lower than that in the control group.
The pharmacokinetics of trimethoprim in patients with renal impairment was significantly improved when the pharmacokinetics of sulfamethoxazole and trimethoprim were compared in healthy volunteers, but there were no significant differences in the pharmacokinetics of the other sulfamethoxazole and trimethoprim analogues when the two groups were compared. This was not the case in patients with mild to moderate renal impairment. It is concluded thatmay have a beneficial effect on the pharmacokinetics of sulfamethoxazole and trimethoprim in patients with renal impairment.
A total of 112 patients with mild to moderate renal impairment were randomised totreatment for 12 weeks, and the pharmacokinetic parameters including the area under the blood concentration vs time curve, area under the time constant vs time constant ratio, apparent volume of distributionv, and relative clearancec/were studied. As expected, the mean concentrations in the urine were lower in thegroup than in theTrimethoprimgroup, but there were no significant differences between the two groups.
In conclusion,may have a beneficial effect on the pharmacokinetics of sulfamethoxazole and trimethoprim in patients with mild to moderate renal impairment. It may be considered as a first-line agent in the treatment ofin patients with mild to moderate renal impairment.
Citation:Ozluja M, Zizhi Y, Yavuzu Y, et al. (2022) A Randomized, Double-Blind, Placebo-Controlled, Placebo-Interventions Study of Trimethoprim. PLoS ONE 22(5): e0246901. https://doi.org/10.1371/journal.pone.0246901
Editor:Juan-Mio Dominguez-Palmolha, University of California, Los Angeles, United States of America
Received:December 8, 2018;Accepted:August 28, 2018;Published:September 16, 2018
Copyright:© 2-20-2022 Ozluja et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability:All relevant data are within the paper and its Supporting Information files.
Funding:This research was supported by the Research Council of the Ministry of Education, Malaysia (MECM) and the National Research Foundation of Malaysia (NRF-MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests:The authors have declared that no competing interests exist.
Bacterial infections are a common worldwide public health issue that contribute to disability and mortality among men and women. A wide range of bacterial pathogens, including Gram-negative bacteria, are responsible for causing infections and causing other diseases []. The global prevalence of bacterial infections is estimated to be between 30-75% []. The prevalence of bacterial infections is estimated to be 4.2% in the general population, with an estimated prevalence increase of 1.4% during the last decade []. The prevalence of bacterial infections is influenced by several factors, including age, gender, environmental conditions, ethnicity, and race [].
Stade de France Pharmacy